|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
3.340 -0.120 (-3.468%) | 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
| Turnover | 359,292 | 1.357% | 354,480 | 294,294 | 162,095 | 173,520 |
| Cost of Sales | (139,767) | -8.201% | (152,254) | (127,433) | (71,794) | (77,646) |
| Gross Profit | 219,525 | 8.554% | 202,226 | 166,861 | 90,301 | 95,874 |
| 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (421) | -19.194% | (521) | (307) | 0 | 0 | |
| Profit / (Loss) before Taxation | 37,130 | -16.075% | 44,242 | 41,672 | 16,662 | 24,839 | |
| Taxation | (4,232) | 1.682% | (4,162) | (9,152) | (1,982) | (2,904) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,399) | -- | 90 | (1,275) | (1,336) | (1,150) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 31,499 | -21.586% | 40,170 | 31,245 | 13,344 | 20,785 | |
| 2023/12 - Final USD(K$) | %Chg (Compare to Final) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | 2019/12 USD(K$) | |
| Net Finance Costs / (Income) | 1,842 | 35.541% | 1,359 | 1,462 | 291 | (1,101) |
| Depreciation & Amortisation | 14,235 | 14.780% | 12,402 | 12,285 | 10,462 | 9,725 |
| Directors' Emoluments | 1,681 | -34.464% | 2,565 | 1,711 | 869 | 859 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 6.740 | -21.810% | 8.620 | 6.900 | 3.020 | 4.700 |
| DPS (cts) | 2.020 | -- | 2.204 | 2.008 | 0.900 | 1.400 |
| Dividend Payout Ratio (%) | 29.973% | -- | 25.574% | 29.106% | 29.801% | 29.787% |
| Cash flow per share ($) | 0.094 | -- | 0.047 | 0.072 | 0.058 | 0.048 |
| NBV per share ($) | 0.966 | -- | 0.922 | 0.863 | 0.751 | 0.736 |
| Remarks: | Real time quote last updated: 15/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD 10,952,000 |
| %Change | -42.050% |
| EPS / (LPS) | USD 0.023 |
| NBV Per Share ($) | USD 0.967 |